1,4-Bis(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole

Catalog No. :
ACAVQM292
CAS No. :
876013-29-5
Molecular Formula :
C20H23N3O6
Molecular Weight :
401.42

IUPAC Name:1,4-bis(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole

1,4-Bis(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$116.00Login to see priceIn stockInquiry
50mg98%$197.00Login to see priceIn stockInquiry
100mg98%$335.00Login to see priceIn stockInquiry
250mg98%$636.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Bis(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole
IUPAC Name1,4-bis(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole
Molecular FormulaC20H23N3O6
Molecular Weight401.42
SMILESCOC1=C(OC)C(OC)=CC(C2=CN(C3=CC(OC)=C(OC)C(OC)=C3)N=N2)=C1
InChI KeyAYRNPKFDUZHVBK-UHFFFAOYSA-N
Synonym1H-1,2,3-Triazole, 1,4-bis(3,4,5-trimethoxyphenyl)-;TNF/IFN-γ-IN-1;1,4-Bis(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole
CAS No.876013-29-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACAVQM292 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPOYC973 route compound structure diagram
    ACPOYC97353560-33-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVQM292 route product structure diagram
    ACAVQM292876013-29-5 In Stock
Inquiry

2. ACAVQM292 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWABU721 route compound structure diagram
    ACWABU721182163-96-8 In Stock
  4. Then
  5. ACAVQM292 route product structure diagram
    ACAVQM292876013-29-5 In Stock
Inquiry

Comments (0)